Joachim Rothe
InvestorPartner at EQT Life Sciences
Munich, Germany
Writes $11M – $65M checks · typically $25M
Find your path to Joachim
Sign up to see every warm intro you have to Joachim
- Paths you didn't know you had: your email and LinkedIn already hold routes to Joachim. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Contact· self-published, not guessed
Investments
Investor
Binx HealthCellerixDNA ScriptInnovative MoleculesLuxendoNouscomU3 Pharma
Per curated public sources.
Colleagues at EQT Life Sciences
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Andre Olijslager
Investor at LSP (Life Sciences Partners)
Anne Portwich
Partner at EQT Life Sciences
Anton Pijpers
Investor at LSP (Life Sciences Partners)
Arno de Wilde
Investor at EQT Life Sciences
Bas Vaessen
Investor at LSP (Life Sciences Partners)
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Frequently asked questions
- Who is Joachim Rothe?
- Partner at EQT Life Sciences
- Where does Joachim Rothe work?
- Joachim Rothe is Partner at EQT Life Sciences.
- What check size does Joachim Rothe write?
- Joachim Rothe typically writes checks of $11M – $65M.
- What companies has Joachim Rothe invested in?
- Investments tracked here include Binx Health, Cellerix, DNA Script, Innovative Molecules, Luxendo, Nouscom, U3 Pharma.
About this profile. Compiled from public sources — EQT Life Sciences's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights





